Search filters

List of works by Paolo Pronzato

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

scientific article published on 10 December 2015

A Dose Finding Study for the Combination of Epidoxorubicin and Vinorelbine, Delivered Every Two Weeks with G-CSF Support, in Advanced Breast Cancer

scientific article published on 01 August 1998

A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer.

scientific article

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

scientific article

A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer

scientific article published on 01 August 1999

A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer

scientific article published on 01 June 1998

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

scientific article published on 5 December 2013

A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer

scientific article published on 01 November 1993

A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

scientific article

Adjuvant endocrine therapy for perimenopausal women with early breast cancer.

scientific article

Adjuvant systemic treatment of early breast cancer: the NORA study.

scientific article published on 21 June 2006

Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study

scientific article published on 30 August 2007

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

scientific article published on 11 April 2013

Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients

scientific article published on 01 November 1993

Anthacyclines in non-small cell lung cancer

scientific article published on December 1, 2001

Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.

scientific article

Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO project

scientific article published on 04 March 2010

Breast cancer in elderly women: a different reality? Results from the NORA study

scientific article published on 9 March 2007

CMV infection and pneumonia in hematological malignancies.

scientific article published on September 2003

Carboplatin and etoposide as outpatient treatment of advanced non-small-cell lung cancer

scientific article published on 01 March 1994

Carboplatin and vinorelbine in advanced non-small-cell lung cancer

scientific article published on 01 January 1996

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)

scientific article published on 01 July 1996

Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study

scientific article published on 01 July 1988

Clinical Activity and Cardiac Tolerability of Non-Pegylated Liposomal Doxorubicin in Breast Cancer: A Synthetic Review

scientific article published on November 1, 2011

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis

scientific article published on 27 March 2017

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

scientific article

Corrigendum to “Gene expression profiling in breast cancer: A clinical perspective” [The Breast 22 (2013) 109–120]

article

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial

scientific article

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial

scientific article published on July 2011

Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma

scientific article published on 01 May 1994

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

scientific article published on August 26, 2010

Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors

scientific article published on 8 December 2010

First line chemotherapy of metastatic breast cancer.

scientific article published on May 2006

Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy

scientific article published on May 4, 2013

Gene expression profiling in breast cancer: a clinical perspective.

scientific article published on 23 February 2013

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials

scientific article

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials

scientific article published on 25 December 2007

HER2-positive metastatic breast cancer: a changing scenario

scientific article

High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.

scientific article

High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study

scientific article published on 01 January 1998

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

scientific article published on 18 January 2017

Hormonotherapy of advanced prostate cancer.

scientific article

Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.

scientific article published on 7 May 2009

In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.

scientific article published in December 1990

Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

scientific article published on 01 April 2000

Letrozole withdrawal response in locally advanced breast cancer

scientific article published on 11 May 2011

Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach

scientific article published on 01 January 1995

Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study

scientific article published on 01 January 1996

Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives.

scientific article published on 17 August 2010

Lymphoblastoid interferon in advanced breast cancer: a phase II study

scientific article published on 01 August 1993

Medical approaches to preservation of fertility in female cancer patients.

scientific article published on February 2011

Megestrol acetate: phase II study of a single daily administration in advanced breast cancer

scientific article published on 01 November 1990

Mitoxantrone and 5-fluorouracil modulated by the pure (6S) stereoisomer of leucovorin as second-line chemotherapy for advanced breast cancer

scientific article published on 01 January 1994

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer

scientific article published on 01 February 1992

Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses

scientific article

New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients.

scientific article

New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones.

scientific article published on January 2008

New understanding of the role of anthracyclines in early-stage breast cancer: patient selection considerations.

scientific article published on December 2008

Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancer

scientific article published on 01 January 1991

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial

scientific article published on December 2015

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

scientific article published on 7 September 2015

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.

scientific article published on 29 October 2009

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

scientific article published on 27 August 2015

Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.

scientific article

Pemetrexed for the treatment of non-small cell lung cancer.

scientific article published on 17 May 2013

Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

scientific article published on 01 January 1997

Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC)

scientific article published on 01 January 1988

Randomized cooperative study of perioperative chemotherapy in breast cancer

scientific article published on 01 November 1995

Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

scientific article published on 27 June 2007

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

scientific article published on 01 January 1994

Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer

scientific article

Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients

scientific article published on 12 August 2016

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

scientific article published on January 2014

Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer

scientific article published on 01 October 1997

Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review

scientific article published on 8 December 2015

Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.

scientific article

Stevens-Johnson syndrome after treatment with bendamustine

scientific article published on 03 April 2012

Stimulation of human breast cancer in vivo. Experimental findings and clinical results

scientific article published on 01 November 1993

Sublethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low prosenescent doses of epirubicin: the protective role of dexrazoxane.

scientific article published on 19 October 2009

Survival of patients with relapsing breast cancer: analysis of 302 patients

scientific article published on 01 January 1986

Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity.

scientific article published on 10 September 2009

Tamoxifen and alpha interferon in advanced breast cancer

scientific article published on 01 December 1991

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

scientific article published on January 1996

Tamoxifen rechallenge

scientific article published on 01 April 1988

The OECI certification/designation program: the Genoa experience.

scientific article

The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib.

scientific article published on 21 February 2012

The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs).

scientific article

The role of lonidamine in the treatment of breast cancer patients

scientific article published on 01 November 1993

The role of surgery in the combined treatment of locally advanced breast cancer

scientific article published on 01 January 1989

The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival.

scientific article published in February 2014

Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy

scientific article

Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group

scientific article published on 17 October 2007

Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.

scientific article published on May 2004

Trastuzumab Emtansine in the Treatment of HER-2 -Positive Metastatic Breast Cancer Patients

scientific article published on July 1, 2013

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

scientific article published on 16 October 2012

Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?

scientific article published on 29 April 2010

Treatment options in HR⁺/HER2⁻ advanced breast cancer patients pretreated with nonsteroidal aromatase inhibitors: what does current evidence tell us?

scientific article published on 18 September 2014

Use in current clinical practice of 70-gene signature in early breast cancer

article

What do advanced cancer patients know of their disease? A report from Italy

scientific article published on 01 July 1994